Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

A prophylactic α-Gal-based glycovaccine effectively protects against murine acute Chagas disease.

Portillo S, Zepeda BG, Iniguez E, Olivas JJ, Karimi NH, Moreira OC, Marques AF, Michael K, Maldonado RA, Almeida IC.

NPJ Vaccines. 2019 Mar 22;4:13. doi: 10.1038/s41541-019-0107-7. eCollection 2019.

2.

Purification of Glycosylphosphatidylinositol-Anchored Mucins from Trypanosoma cruzi Trypomastigotes and Synthesis of α-Gal-Containing Neoglycoproteins: Application as Biomarkers for Reliable Diagnosis and Early Assessment of Chemotherapeutic Outcomes of Chagas Disease.

Ortega-Rodriguez U, Portillo S, Ashmus RA, Duran JA, Schocker NS, Iniguez E, Montoya AL, Zepeda BG, Olivas JJ, Karimi NH, Alonso-Padilla J, Izquierdo L, Pinazo MJ, de Noya BA, Noya O, Maldonado RA, Torrico F, Gascon J, Michael K, Almeida IC.

Methods Mol Biol. 2019;1955:287-308. doi: 10.1007/978-1-4939-9148-8_22.

3.

Evaluation of Related Risk Factors in Number of Musculoskeletal Disorders Among Carpet Weavers in Iran.

Karimi N, Moghimbeigi A, Motamedzade M, Roshanaei G.

Saf Health Work. 2016 Dec;7(4):322-325. Epub 2016 Apr 27.

Supplemental Content

Loading ...
Support Center